CoChat

Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders

Open access
Boivin, Manon, Pfister, Véronique, Gaucherot, Angeline, Ruffenach, Frank, Negroni, Luc, Sellier, Chantal, Charlet‐Berguerand, Nicolas · 2020 · The EMBO Journal

The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Expansion of G4C2 repeats within the C9ORF72 gene is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Such repeats lead to decreased expression of the autophagy regulator C9ORF72 protein. Furthermore, sense and antisense repeats are translated into toxic dipeptide repeat (DPR) proteins. It is unclear how these repeats are translated, and in which way their translation and the reduced expression of C9ORF72 modulate repeat toxicity. Here, we found that sense and antisense repeats are translated upon initiation at canonical AUG or near‐cognate start codons, resulting in polyGA‐, polyPG‐, and to a lesser degree polyGR‐DPR proteins. However, accumulation of these proteins is prevented by autophagy. Importantly, reduced C9ORF72 levels lead to suboptimal autophagy, thereby impairing clearance of DPR proteins and causing their toxic accumulation, ultimately resulting in neuronal cell death. Of clinical importance, pharmacological compounds activating autophagy can prevent neuronal cell death caused by DPR proteins accumulation. These results suggest the existence of a double‐hit pathogenic mechanism in ALS/FTD, whereby reduced expression of C9ORF72 synergizes with DPR protein accumulation and toxicity. An expansion of G4C2 repeats in the C9ORF72 gene causes amyotrophic lateral sclerosis (ALS). Here, cell transfection and mass spectrometry indicate that G4C2 repeats are translated through classical initiation to cognate ATG or near‐cognate start codons. Furthermore, impaired autophagy due to reduced expression of the C9ORF72 protein synergizes toxicity of G4C2 translation. ALS‐linked sense and antisense repeats are translated into toxic peptides that require clearance by C9ORF72‐dependent autophagy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2018100574

Cites

107 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure EV1 Expanded G4C2 repeats are translated into polyGA AScheme and sequence of the human C9ORF72 sense transcript with 80 G4C2 repeats fused to the eGFP in the three possible frames and cloned into the pcDNA3.1 plasmid.B, CFluorescence (B) and RT–qPCR (C) GFP analyses of HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence and fused in all three possible frames with the GFP deleted of its ATG.D, EGFP expression (D) and immunoblotting (E) analysis of HEK293 cells transfected for 24 h with constructs expressing either polyGA, polyGP, or polyGR expressed under an artificial ATG start codon and fused to the GFP.FImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (CTG into CTT) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.GImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (CTG into ATG) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.HRT–qPCR analysis of GFP expression of HEK293 cells transfected for 24 h with either wild‐type or mutant (CTG into CTT or ATG) constructs containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.IImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 20 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GA frame and treated or not with MG132 and/or bafilomycin A1 for 15 h.JRT–qPCR analysis of GFP expression of HEK293 cells transfected for 24 h with either wild‐type or mutant (AGG into CGG) constructs containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GR frame.
Figure EV1 Expanded G4C2 repeats are translated into polyGA AScheme and sequence of the human C9ORF72 sense transcript with 80 G4C2 repeats fused to the eGFP in the three possible frames and cloned into the pcDNA3.1 plasmid.B, CFluorescence (B) and RT–qPCR (C) GFP analyses of HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence and fused in all three possible frames with the GFP deleted of its ATG.D, EGFP expression (D) and immunoblotting (E) analysis of HEK293 cells transfected for 24 h with constructs expressing either polyGA, polyGP, or polyGR expressed under an artificial ATG start codon and fused to the GFP.FImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (CTG into CTT) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.GImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (CTG into ATG) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.HRT–qPCR analysis of GFP expression of HEK293 cells transfected for 24 h with either wild‐type or mutant (CTG into CTT or ATG) constructs containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame.IImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 20 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GA frame and treated or not with MG132 and/or bafilomycin A1 for 15 h.JRT–qPCR analysis of GFP expression of HEK293 cells transfected for 24 h with either wild‐type or mutant (AGG into CGG) constructs containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GR frame.CC BY-NC-ND · PubMed Central
Figure 1 Expanded G4C2 repeats are translated into polyGA and polyGR AImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 and fused in all three possible frames with the GFP deleted of its ATG.BLC‐MS/MS spectra of the N‐terminal part of the GFP‐immunoprecipitated and LysC‐digested polyGA protein expressed as in (A).C, DImmunoblotting against the GFP‐ (C) or the HA‐tag (D) or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 3, 20 or 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to the GFP in the GA frame.EImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected with either a wild‐type or a mutant (AGG into CGG) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GR frame.FScheme of human C9ORF72 sense transcript with intron 1 retained. Expanded G4C2 repeats, CUG and AGG near‐cognate initiation codons, and polyGA and polyGR ORFs are indicated in red. C9ORF72 ORF is indicated in blue.
Figure 1 Expanded G4C2 repeats are translated into polyGA and polyGR AImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 and fused in all three possible frames with the GFP deleted of its ATG.BLC‐MS/MS spectra of the N‐terminal part of the GFP‐immunoprecipitated and LysC‐digested polyGA protein expressed as in (A).C, DImmunoblotting against the GFP‐ (C) or the HA‐tag (D) or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 3, 20 or 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to the GFP in the GA frame.EImmunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected with either a wild‐type or a mutant (AGG into CGG) construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GR frame.FScheme of human C9ORF72 sense transcript with intron 1 retained. Expanded G4C2 repeats, CUG and AGG near‐cognate initiation codons, and polyGA and polyGR ORFs are indicated in red. C9ORF72 ORF is indicated in blue.CC BY-NC-ND · PubMed Central
Figure 2 Expanded C4G2 repeats are translated into polyPG AImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 and fused in all three possible frames with a HA‐tag.BLC‐MS/MS spectra of the N‐terminal part of the HA‐immunoprecipitated and LysC‐digested polyPG protein expressed as in (A).C, DImmunoblotting against the GFP‐ (C) or the HA‐tag (D) or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 3, 10, or 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to the GFP in the PG frame.EScheme of human antisense C9ORF72 transcript. Expanded C4G2 repeats, AUG initiation codon, and polyPG ORF are indicated in red.
Figure 2 Expanded C4G2 repeats are translated into polyPG AImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 and fused in all three possible frames with a HA‐tag.BLC‐MS/MS spectra of the N‐terminal part of the HA‐immunoprecipitated and LysC‐digested polyPG protein expressed as in (A).C, DImmunoblotting against the GFP‐ (C) or the HA‐tag (D) or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 3, 10, or 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to the GFP in the PG frame.EScheme of human antisense C9ORF72 transcript. Expanded C4G2 repeats, AUG initiation codon, and polyPG ORF are indicated in red.CC BY-NC-ND · PubMed Central
Figure EV2 Expanded C4G2 repeats are translated into polyPG A, BFluorescence (A) and RT–qPCR (B) GFP analyses of HEK293 cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence and fused in all three possible frames with the GFP deleted of its ATG.C, DGFP expression (C) and immunoblotting (D) analysis of HEK293 cells transfected for 24 h with constructs expressing either polyPA or polyPR expressed under an artificial ATG start codon and fused to the GFP. Fluorescence of ATG‐polyGP from Fig EV1D is shown as control.EImmunoblotting against HA or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (∆ATG) construct containing 100 C4G2 repeats embedded in the antisense C9ORF72 sequence fused to a HA‐tag in the PG frame.FRT–qPCR GFP expression analysis of HEK293 cells transfected for 24 h with either a wild‐type or a mutant (∆ATG) construct containing 100 C4G2 repeats embedded in the antisense C9ORF72 sequence fused to the GFP in the PG frame.GImmunoblotting against the HA or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a Kozak consensus mutant construct containing 100 C4G2 repeats embedded in antisense C9ORF72 fused to the HA‐tag in the PG frame.HImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 10 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and treated or not with MG132 and/or bafilomycin A1 for 15 h.
Figure EV2 Expanded C4G2 repeats are translated into polyPG A, BFluorescence (A) and RT–qPCR (B) GFP analyses of HEK293 cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence and fused in all three possible frames with the GFP deleted of its ATG.C, DGFP expression (C) and immunoblotting (D) analysis of HEK293 cells transfected for 24 h with constructs expressing either polyPA or polyPR expressed under an artificial ATG start codon and fused to the GFP. Fluorescence of ATG‐polyGP from Fig EV1D is shown as control.EImmunoblotting against HA or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a mutant (∆ATG) construct containing 100 C4G2 repeats embedded in the antisense C9ORF72 sequence fused to a HA‐tag in the PG frame.FRT–qPCR GFP expression analysis of HEK293 cells transfected for 24 h with either a wild‐type or a mutant (∆ATG) construct containing 100 C4G2 repeats embedded in the antisense C9ORF72 sequence fused to the GFP in the PG frame.GImmunoblotting against the HA or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with either a wild‐type or a Kozak consensus mutant construct containing 100 C4G2 repeats embedded in antisense C9ORF72 fused to the HA‐tag in the PG frame.HImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 10 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and treated or not with MG132 and/or bafilomycin A1 for 15 h.CC BY-NC-ND · PubMed Central
Figure 3 Decreased expression of C9ORF72 synergizes DPR protein toxicity Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells transfected for 24 h with either wild‐type or indicated mutant constructs containing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA, PG, or GR frame.Immunoblotting against the GFP, endogenous C9ORF72, or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to the GFP in the GA frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA.Immunoblotting against the HA‐tag, endogenous C9ORF72, or GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA or treated with bafilomycin A1 for 15 h.Immunoblotting against the HA‐tag, endogenous C9ORF72, or GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GR frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA or treated with bafilomycin A1 for 15 h.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and wild‐type or mutant constructs containing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA, PG, or GR frame.Data information: Error bars indicate s.e.m. Student's t‐test, *P < 0.05, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.
Figure 3 Decreased expression of C9ORF72 synergizes DPR protein toxicity Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells transfected for 24 h with either wild‐type or indicated mutant constructs containing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA, PG, or GR frame.Immunoblotting against the GFP, endogenous C9ORF72, or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to the GFP in the GA frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA.Immunoblotting against the HA‐tag, endogenous C9ORF72, or GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA or treated with bafilomycin A1 for 15 h.Immunoblotting against the HA‐tag, endogenous C9ORF72, or GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GR frame and with either a control siRNA or a siRNA targeting C9orf72 mRNA or treated with bafilomycin A1 for 15 h.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and wild‐type or mutant constructs containing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA, PG, or GR frame.Data information: Error bars indicate s.e.m. Student's t‐test, *P < 0.05, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.CC BY-NC-ND · PubMed Central
Figure EV3 Decreased expression of C9ORF72 synergizes DPR toxicity AImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GA frame and treated or not with MG132 and/or bafilomycin A1.BAs in (A) but with cells transfected with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame.C, DLeft panel, representative images of immunofluorescence labeling of endogenous P62/SQSTM1 (C) or ubiquitin (D) and the GFP in GT1‐7 neuronal cells co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and a construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame. Right panel, quantification of the percent of co‐localization of P62 or ubiquitin with polyGA aggregates.EImmunofluorescence labeling of M6PR in GT1‐7 neuronal cells transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA.FImmunofluorescence labeling of EEA1 in GT1‐7 neuronal cells transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA.Data information: Error bars indicate s.e.m. Student's t‐test, ***P < 0.001. n = 3 independent transfection. Scale bars, 10 μm. Nuclei were counterstained with DAPI.
Figure EV3 Decreased expression of C9ORF72 synergizes DPR toxicity AImmunoblotting against the HA‐tag or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA‐tag in the GA frame and treated or not with MG132 and/or bafilomycin A1.BAs in (A) but with cells transfected with 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame.C, DLeft panel, representative images of immunofluorescence labeling of endogenous P62/SQSTM1 (C) or ubiquitin (D) and the GFP in GT1‐7 neuronal cells co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and a construct containing 80 G4C2 repeats embedded in sense C9ORF72 fused to the GFP in the GA frame. Right panel, quantification of the percent of co‐localization of P62 or ubiquitin with polyGA aggregates.EImmunofluorescence labeling of M6PR in GT1‐7 neuronal cells transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA.FImmunofluorescence labeling of EEA1 in GT1‐7 neuronal cells transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA.Data information: Error bars indicate s.e.m. Student's t‐test, ***P < 0.001. n = 3 independent transfection. Scale bars, 10 μm. Nuclei were counterstained with DAPI.CC BY-NC-ND · PubMed Central
Figure 4 Promethazine reduces DPR protein accumulation and toxicity Left panel, immunoblotting against the HA‐tag or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with a construct expressing 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA in the GA frame and treated with 10 μM of the indicated compound for 15 h. Right panel, quantification of polyGA expression relative to the GAPDH.Left panel, immunoblotting against the HA‐tag or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with a construct expressing 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and treated with 10 μM of the indicated compound for 15 h. Right panel, quantification of polyPG expression relative to the GAPDH.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells treated with 1, 3, or 10 μM of promethazine and co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and a construct expressing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA or PG frame.Data information: Error bars indicate s.e.m. Student's t‐test, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.
Figure 4 Promethazine reduces DPR protein accumulation and toxicity Left panel, immunoblotting against the HA‐tag or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with a construct expressing 80 G4C2 repeats embedded in the human sense C9ORF72 sequence fused to a HA in the GA frame and treated with 10 μM of the indicated compound for 15 h. Right panel, quantification of polyGA expression relative to the GAPDH.Left panel, immunoblotting against the HA‐tag or the GAPDH of proteins extracted from Neuro2A cells transfected for 24 h with a construct expressing 100 C4G2 repeats embedded in the human antisense C9ORF72 sequence fused to a HA‐tag in the PG frame and treated with 10 μM of the indicated compound for 15 h. Right panel, quantification of polyPG expression relative to the GAPDH.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells treated with 1, 3, or 10 μM of promethazine and co‐transfected for 24 h with either a control siRNA or a siRNA targeting C9orf72 mRNA and a construct expressing either 80 G4C2 repeats or 100 C4G2 repeats embedded in sense or antisense C9ORF72 fused to the GFP in the GA or PG frame.Data information: Error bars indicate s.e.m. Student's t‐test, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.CC BY-NC-ND · PubMed Central
Figure EV4 Promethazine reduces DPR protein accumulation and toxicity Left panel, immunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with a construct expressing under an artificial ATG start codon 100 GA repeats fused to the GFP (ATG (GA)100× GFP) and treated 15 h with 10 μM of the indicated drug. Right panel, quantification of polyGA expression relative to the GAPDH.Immunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with ATG (GA)100× GFP and treated 15 h with 1, 3, or 10 μM of the indicated drug.Left panel, GFP fluorescence of HEK293 cells transfected for 24 h with ATG (GA)100× GFP and treated with 10 μM of the indicated compound. Scale bars, 10 μm. Nuclei were counterstained with DAPI. Right panel, quantification of polyGA aggregates.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells treated with 1, 3, or 10 μM of promethazine and co‐transfected for 24 h with ATG (GA)100× GFP and either a control siRNA or a siRNA targeting C9orf72 mRNA.Data information: Error bars indicate s.e.m. Student's t‐test, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.
Figure EV4 Promethazine reduces DPR protein accumulation and toxicity Left panel, immunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with a construct expressing under an artificial ATG start codon 100 GA repeats fused to the GFP (ATG (GA)100× GFP) and treated 15 h with 10 μM of the indicated drug. Right panel, quantification of polyGA expression relative to the GAPDH.Immunoblotting against the GFP or the GAPDH of proteins extracted from HEK293 cells transfected for 24 h with ATG (GA)100× GFP and treated 15 h with 1, 3, or 10 μM of the indicated drug.Left panel, GFP fluorescence of HEK293 cells transfected for 24 h with ATG (GA)100× GFP and treated with 10 μM of the indicated compound. Scale bars, 10 μm. Nuclei were counterstained with DAPI. Right panel, quantification of polyGA aggregates.Cell viability (TO‐PRO‐3 FACS staining) of GT1‐7 neuronal cells treated with 1, 3, or 10 μM of promethazine and co‐transfected for 24 h with ATG (GA)100× GFP and either a control siRNA or a siRNA targeting C9orf72 mRNA.Data information: Error bars indicate s.e.m. Student's t‐test, **P < 0.01, and ***P < 0.001. n = 5 independent transfection.CC BY-NC-ND · PubMed Central
Figure 5 Model of C9ORF72 loss‐of‐function and DPR gain‐of‐function toxicity Expanded sense G4C2 and antisense C4G2 repeats are translated into polyGA, polyGR, and polyPG DPR proteins through initiation to near‐cognate codons or a cognate ATG codon embedded in a poor Kozak sequence. Concomitantly, expanded G4C2 repeats promote epigenetic DNA changes that inhibit promoter 1b activity, ultimately resulting in decreased expression of the C9ORF72 protein. Reduced expression of C9ORF72 leads to suboptimal autophagy that promotes the toxic accumulation of polyGA, polyGR, and polyPG DPR proteins, ultimately resulting in neuronal cell death.
Figure 5 Model of C9ORF72 loss‐of‐function and DPR gain‐of‐function toxicity Expanded sense G4C2 and antisense C4G2 repeats are translated into polyGA, polyGR, and polyPG DPR proteins through initiation to near‐cognate codons or a cognate ATG codon embedded in a poor Kozak sequence. Concomitantly, expanded G4C2 repeats promote epigenetic DNA changes that inhibit promoter 1b activity, ultimately resulting in decreased expression of the C9ORF72 protein. Reduced expression of C9ORF72 leads to suboptimal autophagy that promotes the toxic accumulation of polyGA, polyGR, and polyPG DPR proteins, ultimately resulting in neuronal cell death.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 108 references

Cited by

See all 147

Metadata

Authors
Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
  • Sellier, Chantal
  • Charlet‐Berguerand, Nicolas
Venue
The EMBO Journal
Published
2020-01-13
Volume
39
Issue
4
Pages
e100574-e100574
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2999593520
Cited by
137
References
106
Citations by year
2026: 11 · 2025: 17 · 2024: 19 · 2023: 30 · 2022: 14 · 2021: 29 · 2020: 17
FWCI
9.74
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
Funders
  • Agence Nationale de la Recherche (ANR‐10‐LABX‐0030‐INRT, ANR‐10‐IDEX‐0002‐02)
  • European Research Council (ERC‐2012‐StG #310659)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
C9orf72, G4C2 repeat expansion, dipeptide repeat proteins, autophagy, amyotrophic lateral sclerosis, frontotemporal dementia, neuronal cell death, autophagy activators
MeSH terms
C9orf72 Protein, Amyotrophic Lateral Sclerosis, Autophagy, Dipeptides, Humans, Neurons, Proteins, Cell Death, DNA Repeat Expansion, Frontotemporal Dementia, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. https://app.cochat.ai/papers/10.15252/embj.2018100574
The paper
Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N. (2020). Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. The EMBO Journal. https://doi.org/10.15252/embj.2018100574

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.